The Xinjiang Agriculture University of China and the University of Agriculture Faisalabad (UAF) will collaborate to ...

Innovent Biologics has dosed the first subject in the randomised Phase III HeriCare-Ovarian01 trial of IBI354 for treating ...

Zhou is the first surgeon in northeast Ohio to use Arthrex endoscopic technology to treat the issue. Her first surgery was in January 2025, and in February 2025, Zhou performed the procedure on Tuma ...

Investigators assessed frailty prevalence in a nationally representative US cohort and inpatient outcomes among kidney transplant recipients.

The researchers developed a system architecture that transforms traditional electronic neural network operations into optical ...

Imagine fiber optic cables acting as vast sensor networks, detecting vibrations for everything from earthquake warnings to ...

The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...

An oncologist and a Cambridge city councilor were among 11 men whose names were publicly revealed for the first time Friday.

MUSE Microscopy is committed to advancing the field of pathology through innovation and collaboration. We invite you to join us at USCAP25 to experience the future of digital pathology firsthand.

Researchers develop a fabrication technique to overcome design and performance challenges for scalable single-photon ...

Secrets of China's ancient history have been uncovered through a new 2,000-year-old discovery made by archaeologists in the ...

Innovent Biologics begins patient dosing in phase 3 study of IBI354 for platinum-resistant ovarian cancer: San Francisco Tuesday, March 25, 2025, 18:00 Hrs [IST] Innovent Biologic ...